RxDoctor Payments Data

Emily Clotfelter, PA

Physician Assistant · Harrogate, TNNPI 1265140594

Payments from drug & device makers

$879in general payments, 2019–2025

Across 48 payments — averaging $18.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$218
  • Organogenesis Inc.$119
  • AstraZeneca$107
  • AbbVie$91
  • Lilly USA, LLC$86
  • GSK$67
  • plus $191 from 6 others

What the payments were for

  • Food & beverage$879100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$879 in reported general payments places this provider in the 65th percentile of 2,404 physician assistant providers in Tennessee.

See all physician assistant providers in Tennessee

Medicare billing

Part B allowed, 2024
$13,985
Medicare patients
52
Services billed
602

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide57$89,267
Trelegy ElliptaFluticasone/Umeclidin/Vilanter55$61,578
Breztri AerosphereBudesonide/Glycopyr/Formoterol64$57,240
WegovySemaglutide23$43,571
EliquisApixaban55$43,569
Repatha SureclickEvolocumab49$41,986
FarxigaDapagliflozin Propanediol39$40,955
OzempicSemaglutide26$30,669
VraylarCariprazine Hcl17$24,829
LinzessLinaclotide22$14,623
MyrbetriqMirabegron18$13,522
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen306$8,467
Dexlansoprazole DrDexlansoprazole11$4,023
Albuterol Sulfate HfaAlbuterol Sulfate98$3,852
SymbicortBudesonide/Formoterol Fumarate13$3,764

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaBreztri Aerosphere, Farxiga, Symbicort$107$101,959116 claims
Lilly USA, LLCMounjaro$86$89,26757 claims
Novo NordiskWegovy, Ozempic$47$74,24049 claims
GSKTrelegy Ellipta$67$61,57855 claims
AbbVieVraylar, Linzess$91$39,45239 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,404 physician assistant providers in Tennessee.

Other physician assistant in Harrogate

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →